Pretty sure thats whats happened. They had discussions with Medsafe and then said they would need further trial data before marketing. No announcement was ever made in regard to the Medsafe discussions and no announcement of a formal submission. Then the news that they had called in experts to review the results which were accepted as "relevant" but didn't meet the criteria for significance.
So the trial has been declared a success on the basis of safety and sufficient indications of efficacy at the 80mc dose to allow the DSMB to permit a future phase 3 trial. But since Medsafe hasn't given permission for them to sell it in NZ, the patients can't be asked to fund their own treatment. So now it seems they will need to find a someone with deepish pockets to cough up the necessary funding for a trial.
- Forums
- ASX - By Stock
- Ann: Preliminary Final Report and 2019 Financial Statements
Pretty sure thats whats happened. They had discussions with...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.18M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 2463308 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 274836 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 2463308 | 0.009 |
10 | 5309181 | 0.008 |
7 | 6280009 | 0.007 |
6 | 2493750 | 0.006 |
4 | 2300000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 274836 | 3 |
0.011 | 1127832 | 9 |
0.012 | 2385405 | 7 |
0.013 | 894768 | 4 |
0.014 | 126665 | 2 |
Last trade - 16.12pm 10/07/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
Day chart unavailable
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online